跳至主要内容
临床试验/EUCTR2021-000592-36-DE
EUCTR2021-000592-36-DE招募中1 期

Calcitonin Gene-Related Peptide Receptor Antagonists for Prevention of Acute Mountain Sickness

niversitätsklinikum Essen0 个研究点目标入组 30 人开始时间: 2023年1月13日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • - Age 18-60 years
  • - Good physical condition
  • - No relevant pathologies revealed upon the pre-examination prior to the study
  • - Written informed consent to participate in the study
  • - Permanent residency below 1000 m
  • - Males and females are included without prioritization
  • - More than 3 weeks since vaccination against or full recovery from SARS-CoV2 infection
  • - Negative serum or urine pregnancy test in women of childbearing potential if pregnancy cannot be ruled out
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Intolerance against erenuma or any drug component
  • - Acute and chronic lung diseases
  • - Cardiovascular diseases other than hypertension (coronary heart disease, heart failure, atrial fibrillation, peripheral artery disease)
  • - Conventional systolic blood pressure =150 mmHg and conventional diastolic blood pressure =95 mmHg (average of two measurements) in untreated or treated subjects
  • - Chronic headache / migraine
  • - Diabetes mellitus
  • - Smoking (>6 cigarettes/day) or equivalent nicotine substitutes
  • - Alcohol (>30 g/d) or drug abuse
  • - Obesity (Body Mass Index >30)
  • - Other conditions deemed relevant by the investigator (including liver disease, renal disease, thyroid disorders, Parkinson disease, pheochromocytoma)
  • - Sojourn >2000 m within the last 8 weeks before the 1st study day
  • - Drug intake within the last 2 moth before the 1st study day if the drug intake could affect the data quality (eg. corticosteroids) or the safety of the participants (eg. anti-coagulants)
  • - Blood donation within the last 2 month before the 1st study day
  • - Pregnant or nursing women
  • - Participation in other clinical trials

研究者

发起方
niversitätsklinikum Essen

相似试验